Position in TVTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$15,341,423
+$6,267,637 QoQ
Shares Held
270,048
-11.6% QoQ
Ownership
0.286%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#62
of 315 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in TVTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AQR CAPITAL MANAGEMENT LLC holds $5,647,082,398 across 216 Biotechnology names. TVTX ranks #35 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,126,080 | $702,155,918 | |
| 2 | INCY |
Incyte Corp
|
5,320,901 | $603,177,333 | |
| 3 | EXEL |
Exelixis, Inc.
|
11,023,943 | $599,812,735 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,522,568 | $366,893,205 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
5,699,541 | $326,127,732 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
616,170 | $306,070,117 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
1,295,450 | $242,611,869 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,305,412 | $241,404,446 |
All Filings in TVTX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,341,423 | 270,048 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $9,073,786 | 305,412 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $13,477,314 | 352,717 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $7,489,708 | 313,377 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $3,375,775 | 228,093 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $7,155,633 | 399,310 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $7,386,496 | 424,024 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $2,723,334 | 194,663 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $608,845 | 74,069 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $366,872 | 47,584 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $154,475 | 17,183 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $431,363 | 48,251 | Shares | Defined | 2023-11-14 | |
| 2023-03-31 | $222,606 | 9,898 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $384,554 | 18,286 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $763,273 | 30,977 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $597,754 | 24,670 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,634,410 | 63,423 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,334,797 | 75,219 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,570,478 | 64,762 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,177,879 | 80,732 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,143,650 | 45,801 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $813,752 | 29,857 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 RTRX | — | 26,799 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 RTRX | — | 29,924 | Shares | Defined | 2020-08-17 | |
| No filing history on record for this holder in this stock. | ||||||